Development of Stroke Diagnostic Technology

Stroke is an acute cerebrovascular disease with rapid onset and high mortality. At the same time, it is difficult for unusual drugs to cross the blood brain barrier for effective treatment because its lesion site is in the brain. The time window for intravenous thrombolysis is 4.5 h after stroke, which is the best time to treat stroke. However, because of the narrow window, stroke patients often miss the best time for treatment even before the diagnosis is made. Therefore, timely and effective techniques to diagnose stroke are essential. Although there have been some studies on stroke diagnosis, the complexity of stroke pathology and its similarity to many diseases make rapid and accurate stroke diagnosis difficult. Based on the current research, Ace Therapeutics has developed a series of techniques for diagnosing stroke with the aim of facilitating research and development of stroke diagnosis.

Development of Exosome - Based Stroke Diagnostic Technology

The exosome is rich in functional contents, including proteins, nucleic acids, lipids, and other metabolites. As a result, it tends to respond to changes in the body quickly and accurately. It has been shown that some of the contents of exosomes in blood and cerebrospinal fluid change rapidly after the onset of stroke and can therefore be used for rapid diagnosis of stroke. However, there are no definitive studies on exosome-based stroke diagnosis. Therefore, Ace Therapeutics offers comprehensive services to facilitate the development of exosome-based stroke diagnosis.

Development of RNA - Based Stroke Diagnostic Technology

RNA always responds to changes in the body by changing its own type and abundance more rapidly, so there are many studies to develop stroke diagnosis based on RNA. However, due to the complexity of stroke pathology and its similarity to some neurological diseases, there are no clear studies to determine which RNAs can be used for stroke diagnosis. In view of the importance and necessity of stroke diagnosis in the stroke treatment process, Ace Therapeutics offers the services of developing stroke diagnostics based on RNA with the aim of facilitating the development of stroke diagnostic techniques.

Neuroimaging for Stroke Diagnosis

Neuroimaging techniques play an important role in stroke diagnosis. Neuroimaging of animal models allows real-time monitoring of brain dynamics during stroke onset as well as provides initial determination of the location and extent of the infarct core and penumbra regions, characterization of vascular status, and other physiological and pathological information on stroke. This technology facilitates stroke research while guiding subsequent treatment. Therefore, Ace Therapeutics provides a comprehensive stroke specific neuroimaging technique service to facilitate stroke research and advance stroke diagnostic techniques.

Why Choose Us

With decades of focus on stroke research, Ace Therapeutics has a wealth of expertise and experience in the field of stroke.

We continue to keep abreast of the times and focus on solving key and difficult problems in the stroke field.
We understand the importance of stroke diagnosis in stroke treatment and are constantly honing our skills in stroke diagnosis development in order to accelerate your stroke diagnosis research and speed up the fight against stroke.

If you would like to learn more about our services, please feel free to contact us.

All of our services are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.